A17V (p.Ala17Val) variant of SLC35A2 (UDP-galactose translocator)
A17V (p.Ala17Val) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.15 / 1. The record also includes population frequency data and structural context.
A17V (p.Ala17Val) variant details
- p.Ala17Val
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.152
- REVEL 0.03
- CADD 3.81
- PolyPhen-2 0.00
- SIFT 0.42
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available